XNAS 07 Nov, 2025 4:30 PM (EST)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 200.29 per share. | 04 Nov 2025 | 17,198 | 2,286,554 (2%) | 0% | 200.3 | 3,444,565 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 201.18 per share. | 04 Nov 2025 | 5,702 | 2,280,852 (2%) | 0% | 201.2 | 1,147,109 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2025 | 17,100 | 2,303,752 (2%) | 0% | 200.0 | 3,420,003 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 3,595 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 2,084 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2025 | 156,573 | 144,816 (0%) | 0% | 200.0 | 31,314,334 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 198.96 per share. | 03 Nov 2025 | 1,915 | 301,389 (0%) | 0% | 199.0 | 381,012 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 198.03 per share. | 03 Nov 2025 | 2,215 | 303,304 (0%) | 0% | 198.0 | 438,635 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.75 per share. | 03 Nov 2025 | 150,000 | 305,519 (0%) | 0% | 119.8 | 17,962,500 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.01 per share. | 03 Nov 2025 | 2,084 | 151,924 (0%) | 0% | 13.0 | 27,113 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.27 per share. | 03 Nov 2025 | 3,595 | 155,519 (0%) | 0% | 20.3 | 72,871 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 150,000 | 0 | - | - | Stock Option (right to buy) | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2025 | 2,000 | 26,032 (0%) | 0% | 200 | 400,000 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 200.14 per share. | 03 Nov 2025 | 2,000 | 26,032 (0%) | 0% | 200.1 | 400,274 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 198.03 per share. | 03 Nov 2025 | 1,450 | 113,611 (0%) | 0% | 198.0 | 287,138 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 199.74 per share. | 03 Nov 2025 | 100 | 112,061 (0%) | 0% | 199.7 | 19,974 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 199.10 per share. | 03 Nov 2025 | 1,450 | 112,161 (0%) | 0% | 199.1 | 288,698 | Common Stock |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 97 | 5,316 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 149 | 6,839 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 93 | 18,359 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 198.71 per share. | 31 Oct 2025 | 122 | 5,762 (0%) | 0% | 198.7 | 24,243 | Common Stock |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 121 | 5,884 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 93 | 5,221 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 128 | 6,143 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 288 | 235,921 (0%) | 0% | 192.3 | 55,389 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 191 | 235,730 (0%) | 0% | 191.5 | 36,569 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 188.37 per share. | 27 Oct 2025 | 300 | 65,693 (0%) | 0% | 188.4 | 56,512 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.20 per share. | 27 Oct 2025 | 200 | 65,993 (0%) | 0% | 192.2 | 38,439 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.51 per share. | 27 Oct 2025 | 404 | 66,193 (0%) | 0% | 191.5 | 77,369 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 189.90 per share. | 27 Oct 2025 | 574 | 66,597 (0%) | 0% | 189.9 | 109,001 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,237 | 67,171 (0%) | 0% | 191.5 | 236,838 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 781 | 68,408 (0%) | 0% | 192.3 | 150,205 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 190.99 per share. | 27 Oct 2025 | 667 | 64,626 (0%) | 0% | 191.0 | 127,391 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.12 per share. | 27 Oct 2025 | 500 | 64,126 (0%) | 0% | 192.1 | 96,058 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 189.91 per share. | 27 Oct 2025 | 400 | 65,293 (0%) | 0% | 189.9 | 75,963 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 3,680 | 149,840 (0%) | 0% | 191.5 | 704,580 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 2,335 | 153,520 (0%) | 0% | 192.3 | 449,077 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,058 | 201,699 (0%) | 0% | 191.5 | 202,567 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 935 | 202,757 (0%) | 0% | 192.3 | 179,823 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 1,008 | 116,259 (0%) | 0% | 192.3 | 193,863 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 1,198 | 115,061 (0%) | 0% | 191.5 | 229,371 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 191.46 per share. | 27 Oct 2025 | 928 | 150,699 (0%) | 0% | 191.5 | 177,677 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 27 Oct 2025 | 781 | 151,627 (0%) | 0% | 192.3 | 150,205 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 1,250 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 196.77 per share. | 22 Oct 2025 | 755 | 69,189 (0%) | 0% | 196.8 | 148,561 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 187.16 per share. | 22 Oct 2025 | 495 | 69,944 (0%) | 0% | 187.2 | 92,644 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 1,250 | 70,439 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 186.68 per share. | 22 Oct 2025 | 920 | 69,189 (0%) | 0% | 186.7 | 171,746 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 21 Oct 2025 | 292 | 117,267 (0%) | 0% | 187.9 | 54,881 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 21 Oct 2025 | 339 | 152,408 (0%) | 0% | 187.9 | 63,715 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 190.00 per share. | 20 Oct 2025 | 10,000 | 5,000 (0%) | 0% | 190 | 1,900,000 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 93 | 236,209 (0%) | 0% | 187.9 | 17,479 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 190 | 236,302 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 190 | 191 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 1,522 | 70,711 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 1,522 | 1,522 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 602 | 70,109 (0%) | 0% | 188.0 | 113,146 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 3,386 | 157,458 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 1,603 | 155,855 (0%) | 0% | 188.0 | 301,284 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 3,386 | 3,386 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 187.95 per share. | 20 Oct 2025 | 464 | 203,692 (0%) | 0% | 188.0 | 87,209 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 856 | 204,156 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 856 | 856 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 178.66 per share. | 15 Oct 2025 | 475 | 28,307 (0%) | 0% | 178.7 | 84,864 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 176.62 per share. | 15 Oct 2025 | 423 | 236,112 (0%) | 0% | 176.6 | 74,712 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 175.90 per share. | 15 Oct 2025 | 988 | 236,535 (0%) | 0% | 175.9 | 173,786 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 175.11 per share. | 15 Oct 2025 | 1,506 | 237,523 (0%) | 0% | 175.1 | 263,715 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 172.99 per share. | 15 Oct 2025 | 153 | 239,029 (0%) | 0% | 173.0 | 26,468 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.29 per share. | 15 Oct 2025 | 337 | 28,032 (0%) | 0% | 179.3 | 60,421 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 178.58 per share. | 15 Oct 2025 | 413 | 28,369 (0%) | 0% | 178.6 | 73,754 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.35 per share. | 15 Oct 2025 | 275 | 28,032 (0%) | 0% | 179.4 | 49,322 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.96 per share. | 01 Oct 2025 | 404 | 120,155 (0%) | 0% | 159.0 | 64,220 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 159.91 per share. | 01 Oct 2025 | 1,816 | 118,339 (0%) | 0% | 159.9 | 290,402 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 160.70 per share. | 01 Oct 2025 | 780 | 117,559 (0%) | 0% | 160.7 | 125,347 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 6,250 | 71,680 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 6,250 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 162.05 per share. | 29 Sep 2025 | 2,491 | 69,189 (0%) | 0% | 162.1 | 403,674 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 18,750 | 177,264 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 159.78 per share. | 29 Sep 2025 | 9,003 | 158,518 (0%) | 0% | 159.8 | 1,438,535 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 158.84 per share. | 29 Sep 2025 | 634 | 167,521 (0%) | 0% | 158.8 | 100,707 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 162.05 per share. | 29 Sep 2025 | 9,109 | 168,155 (0%) | 0% | 162.1 | 1,476,139 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 18,750 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 161.47 per share. | 29 Sep 2025 | 470 | 154,072 (0%) | 0% | 161.5 | 75,892 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 160.49 per share. | 29 Sep 2025 | 3,976 | 154,542 (0%) | 0% | 160.5 | 638,099 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 2,500 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 162.05 per share. | 29 Sep 2025 | 1,364 | 203,300 (0%) | 0% | 162.1 | 221,040 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 2,500 | 204,664 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 181.28 per share. | 18 Sep 2025 | 1,188 | 2,320,852 (2%) | 0% | 181.3 | 215,363 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 18 Sep 2025 | 10,000 | 15,000 (0%) | 0% | 180 | 1,800,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 180.13 per share. | 18 Sep 2025 | 14,473 | 2,346,379 (2%) | 0% | 180.1 | 2,607,069 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 180.54 per share. | 18 Sep 2025 | 24,339 | 2,322,040 (2%) | 0% | 180.5 | 4,394,236 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 180.68 per share. | 17 Sep 2025 | 676 | 28,782 (0%) | 0% | 180.7 | 122,138 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.88 per share. | 17 Sep 2025 | 1,380 | 29,458 (0%) | 0% | 179.9 | 248,240 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 176.61 per share. | 17 Sep 2025 | 256 | 239,182 (0%) | 0% | 176.6 | 45,212 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 175.88 per share. | 17 Sep 2025 | 2,814 | 239,438 (0%) | 0% | 175.9 | 494,936 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.08 per share. | 17 Sep 2025 | 3,444 | 30,838 (0%) | 0% | 179.1 | 616,748 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 180.68 per share. | 17 Sep 2025 | 380 | 28,782 (0%) | 0% | 180.7 | 68,659 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 180.06 per share. | 17 Sep 2025 | 1,518 | 29,162 (0%) | 0% | 180.1 | 273,329 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 179.09 per share. | 17 Sep 2025 | 3,602 | 30,680 (0%) | 0% | 179.1 | 645,093 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2025 | 300 | 120,559 (0%) | 0% | 0 | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 170.31 per share. | 12 Sep 2025 | 4,500 | 25,500 (0%) | 0% | 170.3 | 766,387 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 172.64 per share. | 12 Sep 2025 | 500 | 25,000 (0%) | 0% | 172.6 | 86,320 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.69 per share. | 02 Sep 2025 | 1,907 | 158,514 (0%) | 0% | 167.7 | 319,779 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.44 per share. | 02 Sep 2025 | 1,700 | 161,893 (0%) | 0% | 165.4 | 281,243 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 166.29 per share. | 02 Sep 2025 | 1,472 | 160,421 (0%) | 0% | 166.3 | 244,773 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 166.39 per share. | 02 Sep 2025 | 500 | 122,069 (0%) | 0% | 166.4 | 83,195 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.69 per share. | 02 Sep 2025 | 1,290 | 122,569 (0%) | 0% | 165.7 | 213,735 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.71 per share. | 02 Sep 2025 | 1,210 | 120,859 (0%) | 0% | 167.7 | 202,935 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 155.46 per share. | 12 Aug 2025 | 867 | 123,867 (0%) | 0% | 155.5 | 134,784 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 155.38 per share. | 12 Aug 2025 | 8 | 123,859 (0%) | 0% | 155.4 | 1,243 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 1,675 | 124,734 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 155.33 per share. | 12 Aug 2025 | 6 | 152,747 (0%) | 0% | 155.3 | 932 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 155.46 per share. | 12 Aug 2025 | 672 | 152,753 (0%) | 0% | 155.5 | 104,469 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 1,675 | 153,425 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 156.40 per share. | 08 Aug 2025 | 100 | 245,222 (0%) | 0% | 156.4 | 15,640 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 149.57 per share. | 08 Aug 2025 | 120 | 35,662 (0%) | 0% | 149.6 | 17,948 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 151.12 per share. | 08 Aug 2025 | 300 | 35,362 (0%) | 0% | 151.1 | 45,337 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.40 per share. | 08 Aug 2025 | 180 | 35,182 (0%) | 0% | 152.4 | 27,432 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.04 per share. | 08 Aug 2025 | 270 | 34,912 (0%) | 0% | 154.0 | 41,592 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.74 per share. | 08 Aug 2025 | 610 | 34,302 (0%) | 0% | 155.7 | 95,003 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 156.30 per share. | 08 Aug 2025 | 20 | 34,282 (0%) | 0% | 156.3 | 3,126 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.79 per share. | 08 Aug 2025 | 639 | 34,282 (0%) | 0% | 155.8 | 99,553 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.60 per share. | 08 Aug 2025 | 191 | 34,921 (0%) | 0% | 154.6 | 29,528 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.73 per share. | 08 Aug 2025 | 200 | 35,112 (0%) | 0% | 152.7 | 30,546 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 150.95 per share. | 08 Aug 2025 | 470 | 35,312 (0%) | 0% | 151.0 | 70,948 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.52 per share. | 08 Aug 2025 | 200 | 242,252 (0%) | 0% | 164.5 | 32,903 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.88 per share. | 08 Aug 2025 | 800 | 242,452 (0%) | 0% | 163.9 | 131,107 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.73 per share. | 08 Aug 2025 | 1,030 | 243,252 (0%) | 0% | 162.7 | 167,616 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.68 per share. | 08 Aug 2025 | 639 | 244,282 (0%) | 0% | 159.7 | 102,033 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.63 per share. | 08 Aug 2025 | 301 | 244,921 (0%) | 0% | 158.6 | 47,748 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 133.66 per share. | 01 Aug 2025 | 1,183 | 5,763 (0%) | 0% | 133.7 | 158,116 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 132.73 per share. | 01 Aug 2025 | 1,313 | 6,946 (0%) | 0% | 132.7 | 174,278 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 132.43 per share. | 01 Aug 2025 | 2,810 | 166,590 (0%) | 0% | 132.4 | 372,118 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 133.31 per share. | 01 Aug 2025 | 2,997 | 163,593 (0%) | 0% | 133.3 | 399,538 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 133.31 per share. | 01 Aug 2025 | 1,326 | 123,159 (0%) | 0% | 133.3 | 176,769 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 132.45 per share. | 01 Aug 2025 | 1,574 | 124,485 (0%) | 0% | 132.5 | 208,481 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 134.08 per share. | 01 Aug 2025 | 100 | 123,059 (0%) | 0% | 134.1 | 13,408 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 1,718 | 2,360,852 (3%) | 0% | 139.8 | 240,191 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 479 | 245,322 (0%) | 0% | 139.8 | 66,968 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 2,019 | 68,475 (0%) | 0% | 139.8 | 282,273 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.01 per share. | 28 Jul 2025 | 1,278 | 65,430 (0%) | 0% | 138.0 | 176,380 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 137.42 per share. | 28 Jul 2025 | 1,200 | 66,708 (0%) | 0% | 137.4 | 164,901 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 136.01 per share. | 28 Jul 2025 | 567 | 67,908 (0%) | 0% | 136.0 | 77,116 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 6,092 | 169,400 (0%) | 0% | 139.8 | 851,712 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 1,994 | 202,164 (0%) | 0% | 139.8 | 278,778 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 2,206 | 126,059 (0%) | 0% | 139.8 | 308,417 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 139.81 per share. | 28 Jul 2025 | 1,710 | 151,750 (0%) | 0% | 139.8 | 239,072 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 153 | 68,629 (0%) | 0% | - | Common Stock | |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 112 | 5,219 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 173 | 6,690 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 108 | 18,266 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 141 | 8,259 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 108 | 5,128 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2025 | 1,250 | 1,250 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.95 per share. | 22 Jul 2025 | 297 | 70,494 (0%) | 0% | 139.9 | 41,565 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.20 per share. | 22 Jul 2025 | 458 | 70,791 (0%) | 0% | 139.2 | 63,755 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 141.28 per share. | 22 Jul 2025 | 495 | 71,249 (0%) | 0% | 141.3 | 69,934 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.58 per share. | 22 Jul 2025 | 920 | 70,494 (0%) | 0% | 139.6 | 128,415 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2025 | 1,250 | 71,744 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 190 | 245,894 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 190 | 381 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 20 Jul 2025 | 93 | 245,801 (0%) | 0% | 139.3 | 12,954 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 1,522 | 3,044 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 20 Jul 2025 | 602 | 71,414 (0%) | 0% | 139.3 | 83,853 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 1,522 | 72,016 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 3,386 | 6,772 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 20 Jul 2025 | 1,622 | 175,492 (0%) | 0% | 139.3 | 225,928 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2025 | 3,386 | 177,114 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 149.96 per share. | 16 Jul 2025 | 3,070 | 245,704 (0%) | 0% | 150.0 | 460,388 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.22 per share. | 02 Jul 2025 | 200 | 37,082 (0%) | 0% | 159.2 | 31,845 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.11 per share. | 02 Jul 2025 | 1,092 | 35,990 (0%) | 0% | 160.1 | 174,835 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.23 per share. | 02 Jul 2025 | 208 | 35,782 (0%) | 0% | 161.2 | 33,535 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.29 per share. | 02 Jul 2025 | 189 | 35,782 (0%) | 0% | 161.3 | 30,483 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.11 per share. | 02 Jul 2025 | 1,011 | 35,971 (0%) | 0% | 160.1 | 161,869 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.14 per share. | 02 Jul 2025 | 300 | 36,982 (0%) | 0% | 159.1 | 47,742 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 167.56 per share. | 01 Jul 2025 | 2,651 | 8,118 (0%) | 0% | 167.6 | 444,189 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 01 Jul 2025 | 4,299 | 12,417 (0%) | 0% | 24.4 | 104,982 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 167.05 per share. | 01 Jul 2025 | 1,648 | 10,769 (0%) | 0% | 167.1 | 275,301 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,299 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 164.00 per share. | 01 Jul 2025 | 1,008 | 178,063 (0%) | 0% | 164.0 | 165,308 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.77 per share. | 01 Jul 2025 | 648 | 173,728 (0%) | 0% | 167.8 | 108,714 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.19 per share. | 01 Jul 2025 | 3,187 | 174,376 (0%) | 0% | 167.2 | 532,839 | Common Stck |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.83 per share. | 01 Jul 2025 | 500 | 177,563 (0%) | 0% | 165.8 | 82,917 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.79 per share. | 01 Jul 2025 | 291 | 130,205 (0%) | 0% | 167.8 | 48,827 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 163.88 per share. | 01 Jul 2025 | 400 | 132,805 (0%) | 0% | 163.9 | 65,551 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.98 per share. | 01 Jul 2025 | 200 | 132,605 (0%) | 0% | 166.0 | 33,197 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 01 Jul 2025 | 2,109 | 130,496 (0%) | 0% | 167.2 | 352,730 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 68,476 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 68,205 (0%) | 0% | - | Common Stock | |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 5,107 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 6,246 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 6,517 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 18,158 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 8,118 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 7,847 (0%) | 0% | - | Common Stock | |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 5,020 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 149 | 8,765 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 166.99 per share. | 27 Jun 2025 | 2,750 | 6,015 (0%) | 0% | 167.0 | 459,223 | Common Stock |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 271 | 8,616 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,143 | 8,345 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 170.18 per share. | 18 Jun 2025 | 10,000 | 213,674 (0%) | 0% | 170.2 | 1,701,795 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 170.63 per share. | 18 Jun 2025 | 7,630 | 206,044 (0%) | 0% | 170.6 | 1,301,911 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 856 | 204,622 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 856 | 1,712 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 18 Jun 2025 | 464 | 204,158 (0%) | 0% | 139.3 | 64,631 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.50 per share. | 18 Jun 2025 | 2,278 | 203,766 (0%) | 0% | 171.5 | 390,671 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.81 per share. | 16 Jun 2025 | 550 | 37,829 (0%) | 0% | 164.8 | 90,644 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.64 per share. | 16 Jun 2025 | 425 | 37,981 (0%) | 0% | 164.6 | 69,972 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.10 per share. | 16 Jun 2025 | 200 | 38,406 (0%) | 0% | 163.1 | 32,620 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.52 per share. | 16 Jun 2025 | 176 | 38,606 (0%) | 0% | 162.5 | 28,603 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.48 per share. | 16 Jun 2025 | 547 | 37,282 (0%) | 0% | 165.5 | 90,519 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.41 per share. | 16 Jun 2025 | 203 | 38,379 (0%) | 0% | 163.4 | 33,172 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.29 per share. | 16 Jun 2025 | 3,070 | 248,774 (0%) | 0% | 167.3 | 513,571 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.50 per share. | 16 Jun 2025 | 200 | 38,582 (0%) | 0% | 162.5 | 32,499 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.41 per share. | 16 Jun 2025 | 699 | 37,282 (0%) | 0% | 165.4 | 115,620 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 164.33 per share. | 10 Jun 2025 | 3,400 | 6,304 (0%) | 0% | 164.3 | 558,734 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 165.04 per share. | 10 Jun 2025 | 600 | 5,704 (0%) | 0% | 165.0 | 99,027 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 156.07 per share. | 02 Jun 2025 | 1,512 | 183,670 (0%) | 0% | 156.1 | 235,972 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 158.33 per share. | 02 Jun 2025 | 1,476 | 179,071 (0%) | 0% | 158.3 | 233,688 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 157.03 per share. | 02 Jun 2025 | 3,123 | 180,547 (0%) | 0% | 157.0 | 490,403 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 156.30 per share. | 02 Jun 2025 | 1,290 | 134,915 (0%) | 0% | 156.3 | 201,629 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 159.12 per share. | 02 Jun 2025 | 100 | 133,205 (0%) | 0% | 159.1 | 15,912 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.37 per share. | 02 Jun 2025 | 465 | 133,305 (0%) | 0% | 158.4 | 73,643 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 157.23 per share. | 02 Jun 2025 | 1,145 | 133,770 (0%) | 0% | 157.2 | 180,028 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 27 May 2025 | 291 | 128,265 (0%) | 0% | 139.3 | 40,533 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 156.85 per share. | 27 May 2025 | 1,649 | 128,556 (0%) | 0% | 156.9 | 258,646 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 139.29 per share. | 27 May 2025 | 339 | 153,460 (0%) | 0% | 139.3 | 47,219 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 156.85 per share. | 27 May 2025 | 1,438 | 153,799 (0%) | 0% | 156.9 | 225,551 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 153.10 per share. | 15 May 2025 | 9,000 | 55,000 (0%) | 0% | 153.1 | 1,377,900 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 153.90 per share. | 15 May 2025 | 10,000 | 45,000 (0%) | 0% | 153.9 | 1,539,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 161.00 per share. | 15 May 2025 | 10,000 | 35,000 (0%) | 0% | 161 | 1,610,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.85 per share. | 15 May 2025 | 5,000 | 30,000 (0%) | 0% | 165.9 | 829,250 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 150.20 per share. | 15 May 2025 | 10,000 | 74,000 (0%) | 0% | 150.2 | 1,502,000 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 152.60 per share. | 15 May 2025 | 10,000 | 64,000 (0%) | 0% | 152.6 | 1,526,000 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 153.95 per share. | 09 May 2025 | 392 | 254,522 (0%) | 0% | 153.9 | 60,348 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.01 per share. | 09 May 2025 | 708 | 38,782 (0%) | 0% | 159.0 | 112,577 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.01 per share. | 09 May 2025 | 383 | 39,490 (0%) | 0% | 158.0 | 60,517 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 157.09 per share. | 09 May 2025 | 409 | 39,873 (0%) | 0% | 157.1 | 64,248 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.77 per share. | 09 May 2025 | 100 | 38,782 (0%) | 0% | 159.8 | 15,977 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.06 per share. | 09 May 2025 | 690 | 38,882 (0%) | 0% | 159.1 | 109,749 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 157.88 per share. | 09 May 2025 | 307 | 39,572 (0%) | 0% | 157.9 | 48,469 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 156.90 per share. | 09 May 2025 | 403 | 39,879 (0%) | 0% | 156.9 | 63,229 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.03 per share. | 09 May 2025 | 100 | 251,844 (0%) | 0% | 164.0 | 16,403 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 163.07 per share. | 09 May 2025 | 400 | 251,944 (0%) | 0% | 163.1 | 65,229 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.31 per share. | 09 May 2025 | 1,231 | 252,344 (0%) | 0% | 162.3 | 199,800 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.76 per share. | 09 May 2025 | 600 | 253,575 (0%) | 0% | 159.8 | 95,859 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.02 per share. | 09 May 2025 | 107 | 254,175 (0%) | 0% | 158.0 | 16,908 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.50 per share. | 09 May 2025 | 240 | 254,282 (0%) | 0% | 155.5 | 37,320 | Common Stock |
| Marcus Gail B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 4,000 | 4,299 | - | - | Stock Option (right to buy) | |
| Leonard Steven Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 148.25 per share. | 01 May 2025 | 2,009 | 190,153 (0%) | 0% | 148.3 | 297,837 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 148.25 per share. | 01 May 2025 | 853 | 138,352 (0%) | 0% | 148.3 | 126,460 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 152.04 per share. | 01 May 2025 | 331 | 136,205 (0%) | 0% | 152.0 | 50,325 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 152.04 per share. | 01 May 2025 | 770 | 185,182 (0%) | 0% | 152.0 | 117,071 | Common Stock |
| B. Gail Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 01 May 2025 | 4,000 | 13,704 (0%) | 0% | 24.4 | 97,680 | Common Stock |
| B. Marcus Gail | Director | Sale of securities on an exchange or to another person at price $ 153.06 per share. | 01 May 2025 | 1,450 | 9,704 (0%) | 0% | 153.1 | 221,941 | Common Stock |
| Leonard Steven Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 151.26 per share. | 01 May 2025 | 2,186 | 185,952 (0%) | 0% | 151.3 | 330,665 | Common Stock |
| B. Gail Marcus | Director | Sale of securities on an exchange or to another person at price $ 151.37 per share. | 01 May 2025 | 672 | 12,096 (0%) | 0% | 151.4 | 101,719 | Common Stock |
| B. Marcus Gail | Director | Sale of securities on an exchange or to another person at price $ 152.22 per share. | 01 May 2025 | 942 | 11,154 (0%) | 0% | 152.2 | 143,392 | Common Stock |
| Gail Marcus B. | Director | Sale of securities on an exchange or to another person at price $ 146.35 per share. | 01 May 2025 | 31 | 13,673 (0%) | 0% | 146.4 | 4,537 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 149.99 per share. | 01 May 2025 | 908 | 137,444 (0%) | 0% | 150.0 | 136,188 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 149.94 per share. | 01 May 2025 | 2,015 | 188,138 (0%) | 0% | 149.9 | 302,130 | Common Stock |
| Gail Marcus B. | Director | Sale of securities on an exchange or to another person at price $ 149.05 per share. | 01 May 2025 | 241 | 13,109 (0%) | 0% | 149.0 | 35,920 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 151.30 per share. | 01 May 2025 | 908 | 136,536 (0%) | 0% | 151.3 | 137,379 | Common Stock |
| Marcus Gail B. | Director | Sale of securities on an exchange or to another person at price $ 147.95 per share. | 01 May 2025 | 323 | 13,350 (0%) | 0% | 147.9 | 47,787 | Common Stock |
| B. Marcus Gail | Director | Sale of securities on an exchange or to another person at price $ 149.96 per share. | 01 May 2025 | 341 | 12,768 (0%) | 0% | 150.0 | 51,138 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 1,718 | 2,362,570 (3%) | 0% | 152.2 | 261,449 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 439 | 254,914 (0%) | 0% | 152.2 | 66,808 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 2,018 | 73,539 (0%) | 0% | 152.2 | 307,104 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 154.74 per share. | 28 Apr 2025 | 1,445 | 70,694 (0%) | 0% | 154.7 | 223,605 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 153.94 per share. | 28 Apr 2025 | 700 | 72,139 (0%) | 0% | 153.9 | 107,761 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.90 per share. | 28 Apr 2025 | 700 | 72,839 (0%) | 0% | 152.9 | 107,030 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 155.44 per share. | 28 Apr 2025 | 200 | 70,494 (0%) | 0% | 155.4 | 31,087 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 6,203 | 192,162 (0%) | 0% | 152.2 | 943,987 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 1,993 | 223,674 (0%) | 0% | 152.2 | 303,300 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Apr 2025 | 75 | 139,205 (0%) | 0% | 0 | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 2,206 | 139,280 (0%) | 0% | 152.2 | 335,714 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 152.18 per share. | 28 Apr 2025 | 1,709 | 155,237 (0%) | 0% | 152.2 | 260,080 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 164 | 66,062 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 142 | 46,260 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 185 | 4,103 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 116 | 16,015 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 1,250 | 2,500 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 150.74 per share. | 22 Apr 2025 | 495 | 76,312 (0%) | 0% | 150.7 | 74,616 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 1,250 | 76,807 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 145.35 per share. | 22 Apr 2025 | 603 | 75,557 (0%) | 0% | 145.3 | 87,645 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 144.31 per share. | 22 Apr 2025 | 308 | 76,160 (0%) | 0% | 144.3 | 44,446 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.46 per share. | 22 Apr 2025 | 194 | 75,557 (0%) | 0% | 152.5 | 29,577 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 152.45 per share. | 22 Apr 2025 | 561 | 75,751 (0%) | 0% | 152.4 | 85,524 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 21 Apr 2025 | 292 | 141,490 (0%) | 0% | 145.5 | 42,498 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 146.75 per share. | 21 Apr 2025 | 4 | 141,486 (0%) | 0% | 146.8 | 587 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 146.00 per share. | 21 Apr 2025 | 4 | 156,946 (0%) | 0% | 146 | 584 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 21 Apr 2025 | 339 | 156,950 (0%) | 0% | 145.5 | 49,338 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 190 | 255,439 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.00 per share. | 20 Apr 2025 | 1 | 255,353 (0%) | 0% | 146 | 146 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 85 | 255,354 (0%) | 0% | 145.5 | 12,371 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 190 | 571 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 1,521 | 77,078 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 602 | 76,476 (0%) | 0% | 145.5 | 87,615 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.12 per share. | 20 Apr 2025 | 8 | 76,468 (0%) | 0% | 146.1 | 1,169 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 1,521 | 4,566 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 1,643 | 198,386 (0%) | 0% | 145.5 | 239,122 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 3,386 | 10,158 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 146.05 per share. | 20 Apr 2025 | 21 | 198,365 (0%) | 0% | 146.0 | 3,067 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 3,386 | 200,029 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 856 | 2,568 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2025 | 856 | 226,137 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 20 Apr 2025 | 464 | 225,673 (0%) | 0% | 145.5 | 67,531 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.17 per share. | 20 Apr 2025 | 6 | 225,667 (0%) | 0% | 146.2 | 877 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 132.04 per share. | 03 Apr 2025 | 1,220 | 257,099 (0%) | 0% | 132.0 | 161,091 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 141.28 per share. | 03 Apr 2025 | 100 | 40,282 (0%) | 0% | 141.3 | 14,128 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 137.08 per share. | 03 Apr 2025 | 260 | 41,522 (0%) | 0% | 137.1 | 35,641 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 138.55 per share. | 03 Apr 2025 | 490 | 41,032 (0%) | 0% | 138.5 | 67,889 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 03 Apr 2025 | 395 | 40,637 (0%) | 0% | 140.0 | 55,301 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 140.94 per share. | 03 Apr 2025 | 355 | 40,282 (0%) | 0% | 140.9 | 50,034 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 140.57 per share. | 03 Apr 2025 | 287 | 40,382 (0%) | 0% | 140.6 | 40,343 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 139.56 per share. | 03 Apr 2025 | 396 | 40,669 (0%) | 0% | 139.6 | 55,265 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 138.57 per share. | 03 Apr 2025 | 477 | 41,065 (0%) | 0% | 138.6 | 66,097 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 136.98 per share. | 03 Apr 2025 | 240 | 41,542 (0%) | 0% | 137.0 | 32,876 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 136.05 per share. | 03 Apr 2025 | 100 | 255,249 (0%) | 0% | 136.1 | 13,605 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 135.24 per share. | 03 Apr 2025 | 300 | 255,349 (0%) | 0% | 135.2 | 40,573 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 133.86 per share. | 03 Apr 2025 | 400 | 255,649 (0%) | 0% | 133.9 | 53,544 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 133.28 per share. | 03 Apr 2025 | 1,050 | 256,049 (0%) | 0% | 133.3 | 139,939 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 01 Apr 2025 | 2,870 | 13,704 (0%) | 0% | 24.4 | 70,085 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 140.17 per share. | 01 Apr 2025 | 1,512 | 11,794 (0%) | 0% | 140.2 | 211,944 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 139.33 per share. | 01 Apr 2025 | 398 | 13,306 (0%) | 0% | 139.3 | 55,455 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.86 per share. | 01 Apr 2025 | 1,130 | 10,834 (0%) | 0% | 7.9 | 8,882 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,870 | 8,299 | - | - | Stock Option (right to buy) | |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,130 | 0 | - | - | Stock Option (right to buy) | |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 142.82 per share. | 01 Apr 2025 | 197 | 9,704 (0%) | 0% | 142.8 | 28,136 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 142.25 per share. | 01 Apr 2025 | 365 | 9,901 (0%) | 0% | 142.3 | 51,923 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 141.13 per share. | 01 Apr 2025 | 1,528 | 10,266 (0%) | 0% | 141.1 | 215,644 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 141.90 per share. | 01 Apr 2025 | 439 | 141,782 (0%) | 0% | 141.9 | 62,294 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 140.70 per share. | 01 Apr 2025 | 1,270 | 142,221 (0%) | 0% | 140.7 | 178,684 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 139.78 per share. | 01 Apr 2025 | 1,291 | 143,491 (0%) | 0% | 139.8 | 180,450 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 6,250 | 78,119 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.35 per share. | 28 Mar 2025 | 68 | 75,557 (0%) | 0% | 138.4 | 9,408 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.41 per share. | 28 Mar 2025 | 2,494 | 75,625 (0%) | 0% | 138.4 | 345,195 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 140.20 per share. | 28 Mar 2025 | 8,027 | 201,999 (0%) | 0% | 140.2 | 1,125,400 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 139.39 per share. | 28 Mar 2025 | 2,515 | 210,026 (0%) | 0% | 139.4 | 350,572 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 138.42 per share. | 28 Mar 2025 | 252 | 212,541 (0%) | 0% | 138.4 | 34,881 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 18,750 | 222,104 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 138.41 per share. | 28 Mar 2025 | 9,311 | 212,793 (0%) | 0% | 138.4 | 1,288,736 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 18,750 | 18,750 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 142.28 per share. | 28 Mar 2025 | 1,334 | 196,643 (0%) | 0% | 142.3 | 189,801 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 141.11 per share. | 28 Mar 2025 | 4,022 | 197,977 (0%) | 0% | 141.1 | 567,557 | Common Stock |
| Monica Bertagnolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 2,877 | 2,877 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 2,500 | 2,500 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.38 per share. | 28 Mar 2025 | 37 | 225,281 (0%) | 0% | 138.4 | 5,120 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 138.41 per share. | 28 Mar 2025 | 1,367 | 225,318 (0%) | 0% | 138.4 | 189,207 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 2,500 | 226,685 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 149.67 per share. | 17 Mar 2025 | 3 | 2,364,288 (3%) | 0% | 149.7 | 449 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 1,124 | 2,364,291 (3%) | 0% | 146.0 | 164,135 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.81 per share. | 17 Mar 2025 | 630 | 258,319 (0%) | 0% | 146.8 | 92,493 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.78 per share. | 17 Mar 2025 | 430 | 41,782 (0%) | 0% | 146.8 | 63,117 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.09 per share. | 17 Mar 2025 | 1,070 | 42,212 (0%) | 0% | 145.1 | 155,251 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.60 per share. | 17 Mar 2025 | 53 | 258,949 (0%) | 0% | 145.6 | 7,717 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 181 | 261,019 (0%) | 0% | 146.0 | 26,431 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.17 per share. | 17 Mar 2025 | 2,017 | 259,002 (0%) | 0% | 145.2 | 292,817 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 146.78 per share. | 17 Mar 2025 | 490 | 41,782 (0%) | 0% | 146.8 | 71,921 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 145.21 per share. | 17 Mar 2025 | 1,010 | 42,272 (0%) | 0% | 145.2 | 146,664 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 149.50 per share. | 17 Mar 2025 | 2 | 71,869 (0%) | 0% | 149.5 | 299 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 790 | 71,871 (0%) | 0% | 146.0 | 115,362 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 6,702 | 203,354 (0%) | 0% | 146.0 | 978,678 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 926 | 224,187 (0%) | 0% | 146.0 | 135,222 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 149.50 per share. | 17 Mar 2025 | 2 | 224,185 (0%) | 0% | 149.5 | 299 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 149.67 per share. | 17 Mar 2025 | 3 | 144,782 (0%) | 0% | 149.7 | 449 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 1,023 | 144,785 (0%) | 0% | 146.0 | 149,386 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 146.03 per share. | 17 Mar 2025 | 793 | 157,291 (0%) | 0% | 146.0 | 115,800 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 149.50 per share. | 17 Mar 2025 | 2 | 157,289 (0%) | 0% | 149.5 | 299 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,893 | 2,415,415 (3%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 12 Mar 2025 | 13,935 | 2,365,715 (3%) | 0% | 148.4 | 2,067,696 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 147.64 per share. | 12 Mar 2025 | 29,967 | 2,379,650 (3%) | 0% | 147.6 | 4,424,187 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 146.58 per share. | 12 Mar 2025 | 4,798 | 2,409,617 (3%) | 0% | 146.6 | 703,296 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 145.37 per share. | 12 Mar 2025 | 1,000 | 2,414,415 (3%) | 0% | 145.4 | 145,369 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 149.00 per share. | 12 Mar 2025 | 300 | 2,365,415 (3%) | 0% | 149 | 44,700 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 411 | 261,200 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,032 | 72,661 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 145.86 per share. | 12 Mar 2025 | 1,014 | 12,690 (0%) | 0% | 145.9 | 147,907 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 149.27 per share. | 12 Mar 2025 | 381 | 9,704 (0%) | 0% | 149.3 | 56,873 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 148.71 per share. | 12 Mar 2025 | 1,682 | 10,085 (0%) | 0% | 148.7 | 250,127 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 147.20 per share. | 12 Mar 2025 | 923 | 11,767 (0%) | 0% | 147.2 | 135,867 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.86 per share. | 12 Mar 2025 | 4,000 | 13,704 (0%) | 0% | 7.9 | 31,440 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 4,000 | 1,130 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 6,702 | 210,056 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 1,740 | 225,113 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,040 | 145,808 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,040 | 158,084 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.75 per share. | 05 Mar 2025 | 10,320 | 204,254 (0%) | 0% | 144.7 | 1,493,794 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.02 per share. | 05 Mar 2025 | 33,776 | 214,574 (0%) | 0% | 144.0 | 4,864,284 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 142.79 per share. | 05 Mar 2025 | 30,298 | 248,350 (0%) | 0% | 142.8 | 4,326,194 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 141.91 per share. | 05 Mar 2025 | 11,978 | 278,648 (0%) | 0% | 141.9 | 1,699,855 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 145.42 per share. | 05 Mar 2025 | 900 | 203,354 (0%) | 0% | 145.4 | 130,878 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 144.12 per share. | 05 Mar 2025 | 1,700 | 144,168 (0%) | 0% | 144.1 | 245,009 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 143.05 per share. | 05 Mar 2025 | 2,700 | 145,868 (0%) | 0% | 143.1 | 386,239 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 142.08 per share. | 05 Mar 2025 | 1,200 | 148,568 (0%) | 0% | 142.1 | 170,499 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 144.97 per share. | 05 Mar 2025 | 400 | 143,768 (0%) | 0% | 145.0 | 57,988 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.82 per share. | 26 Feb 2025 | 50 | 263,439 (0%) | 0% | 155.8 | 7,791 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.64 per share. | 26 Feb 2025 | 96 | 43,282 (0%) | 0% | 162.6 | 15,613 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.64 per share. | 26 Feb 2025 | 296 | 43,378 (0%) | 0% | 161.6 | 47,846 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.85 per share. | 26 Feb 2025 | 744 | 43,674 (0%) | 0% | 160.9 | 119,674 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.88 per share. | 26 Feb 2025 | 292 | 44,418 (0%) | 0% | 158.9 | 46,394 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.67 per share. | 26 Feb 2025 | 72 | 44,710 (0%) | 0% | 155.7 | 11,208 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.64 per share. | 26 Feb 2025 | 100 | 43,282 (0%) | 0% | 162.6 | 16,264 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.58 per share. | 26 Feb 2025 | 336 | 43,382 (0%) | 0% | 161.6 | 54,290 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.76 per share. | 26 Feb 2025 | 704 | 43,718 (0%) | 0% | 160.8 | 113,173 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.77 per share. | 26 Feb 2025 | 296 | 44,422 (0%) | 0% | 158.8 | 46,995 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.66 per share. | 26 Feb 2025 | 64 | 44,718 (0%) | 0% | 155.7 | 9,962 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.06 per share. | 26 Feb 2025 | 590 | 260,789 (0%) | 0% | 162.1 | 95,617 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.04 per share. | 26 Feb 2025 | 1,280 | 261,379 (0%) | 0% | 161.0 | 206,126 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.24 per share. | 26 Feb 2025 | 580 | 262,659 (0%) | 0% | 159.2 | 92,361 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 157.80 per share. | 26 Feb 2025 | 200 | 263,239 (0%) | 0% | 157.8 | 31,561 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 177.77 per share. | 05 Feb 2025 | 1,632 | 149,768 (0%) | 0% | 177.8 | 290,121 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,522 | 151,400 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,675 | 149,878 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 177.77 per share. | 05 Feb 2025 | 663 | 156,044 (0%) | 0% | 177.8 | 117,862 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,675 | 156,707 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 133 | 65,898 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 114 | 46,118 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 151 | 3,918 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 29,345 | 2,412,522 (3%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 3,549 | 263,489 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 92 | 15,899 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 178.19 per share. | 31 Jan 2025 | 1,500 | 70,629 (0%) | 0% | 178.2 | 267,284 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 173.05 per share. | 31 Jan 2025 | 400 | 114,131 (0%) | 0% | 173.1 | 69,220 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 175.39 per share. | 31 Jan 2025 | 3,500 | 110,631 (0%) | 0% | 175.4 | 613,881 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 176.61 per share. | 31 Jan 2025 | 17,140 | 93,491 (0%) | 0% | 176.6 | 3,027,114 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 177.25 per share. | 31 Jan 2025 | 21,362 | 72,129 (0%) | 0% | 177.2 | 3,786,363 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 12,720 | 114,531 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,682 | 290,626 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,353 | 223,373 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 12,720 | 148,203 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 11,832 | 155,032 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,115 | 103,699 (0%) | 0% | 165.9 | 516,681 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.33 per share. | 29 Jan 2025 | 3 | 263,821 (0%) | 0% | 167.3 | 502 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,805 | 263,824 (0%) | 0% | 165.9 | 631,130 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.43 per share. | 29 Jan 2025 | 7 | 253,944 (0%) | 0% | 167.4 | 1,172 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 9,870 | 253,951 (0%) | 0% | 165.9 | 1,637,124 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,730 | 213,022 (0%) | 0% | 165.9 | 618,690 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 2 | 213,020 (0%) | 0% | 167 | 334 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,041 | 216,752 (0%) | 0% | 165.9 | 172,669 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 4,020 | 135,486 (0%) | 0% | 165.9 | 666,792 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.33 per share. | 29 Jan 2025 | 3 | 135,483 (0%) | 0% | 167.3 | 502 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,178 | 139,056 (0%) | 0% | 165.9 | 195,393 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,115 | 143,202 (0%) | 0% | 165.9 | 516,681 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 167.50 per share. | 29 Jan 2025 | 2 | 143,200 (0%) | 0% | 167.5 | 335 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 913 | 146,317 (0%) | 0% | 165.9 | 151,438 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 5,999 | 2,383,181 (3%) | 0% | 165.9 | 995,046 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 29 Jan 2025 | 4 | 2,383,177 (3%) | 0% | 167.3 | 669 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 176.60 per share. | 29 Jan 2025 | 163 | 259,940 (0%) | 0% | 176.6 | 28,786 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 1 | 260,103 (0%) | 0% | 167 | 167 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,053 | 260,104 (0%) | 0% | 165.9 | 174,660 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 2 | 103,697 (0%) | 0% | 167 | 334 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 1 | 106,814 (0%) | 0% | 167 | 167 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,217 | 106,815 (0%) | 0% | 165.9 | 201,862 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 176.60 per share. | 29 Jan 2025 | 1,886 | 101,811 (0%) | 0% | 176.6 | 333,068 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jan 2025 | 588 | 261,157 (0%) | 0% | 0 | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 161.87 per share. | 27 Jan 2025 | 1,442 | 108,032 (0%) | 0% | 161.9 | 233,417 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.80 per share. | 22 Jan 2025 | 687 | 109,733 (0%) | 0% | 171.8 | 118,027 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 1,250 | 110,915 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.09 per share. | 22 Jan 2025 | 495 | 110,420 (0%) | 0% | 171.1 | 84,690 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 172.44 per share. | 22 Jan 2025 | 259 | 109,474 (0%) | 0% | 172.4 | 44,662 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 171.95 per share. | 22 Jan 2025 | 62 | 140,684 (0%) | 0% | 172.0 | 10,661 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 22 Jan 2025 | 24,799 | 140,746 (0%) | 0% | 164.9 | 4,090,565 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 171.96 per share. | 22 Jan 2025 | 53 | 147,230 (0%) | 0% | 172.0 | 9,114 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 22 Jan 2025 | 21,175 | 147,283 (0%) | 0% | 164.9 | 3,492,791 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 191 | 761 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 191 | 262,572 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 144 | 262,716 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 964 | 261,752 (0%) | 0% | 164.9 | 159,011 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 171.86 per share. | 20 Jan 2025 | 7 | 261,745 (0%) | 0% | 171.9 | 1,203 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 144 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,145 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,522 | 134,451 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,145 | 135,596 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 25,867 | 109,729 (0%) | 0% | 164.9 | 4,266,731 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.95 per share. | 20 Jan 2025 | 64 | 109,665 (0%) | 0% | 172.0 | 11,005 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,522 | 6,087 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,775 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 3,386 | 13,544 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 171.97 per share. | 20 Jan 2025 | 194 | 267,629 (0%) | 0% | 172.0 | 33,362 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 78,359 | 267,823 (0%) | 0% | 164.9 | 12,925,223 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,775 | 346,182 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 3,386 | 344,407 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 644 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 21,985 | 217,847 (0%) | 0% | 164.9 | 3,626,399 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.94 per share. | 20 Jan 2025 | 54 | 217,793 (0%) | 0% | 171.9 | 9,285 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 644 | 239,832 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 856 | 239,188 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 856 | 3,424 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 3,043 | 257,415 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 4,966 | 262,381 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 3,043 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 24,348 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 24,348 | 93,199 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 39,730 | 132,929 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 101,812 | 341,021 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 54,175 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 54,175 | 239,209 (0%) | 0% | - | Common Stock |